Concepedia

Amanda F. Cashen

AF

85

Publications

7.8K

Citations

42

H-Index

1999

Active since

Affiliations

Washington University in St. Louis(Current)

Medical College of Wisconsin

The University of Texas MD Anderson Cancer Center

The Ohio State University

Memorial Sloan Kettering Cancer Center

Amanda F. Cashen is an author at Washington University in St. Louis specializing in medicine, oncology, and pathology.

ORCID

Top concepts

Publications per year

1999–2024

85

Publications

85

Standard-of-Care Axicabtagene Ciloleucel for Relapsed or Refractory Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium

Loretta J. Nastoupil, Michael D. Jain, Lei Feng et al. · Journal of Clinical Oncology · 2020 · 752 citations · Full text

Ibrutinib–Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia

Tait D. Shanafelt, Xin V. Wang, Neil E. Kay et al. · New England Journal of Medicine · 2019 · 715 citations · Full text

First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation

Rizwan Romee, Sarah Cooley, Melissa M. Berrien-Elliott et al. · Blood · 2018 · 397 citations · Full text

Impact of Mobilization and Remobilization Strategies on Achieving Sufficient Stem Cell Yields for Autologous Transplantation

Iskra Pusic, Shi Yuan Jiang, Scott Landua et al. · Biology of Blood and Marrow Transplantation · 2008 · 348 citations · Full text

The phase 3 DUO trial: duvelisib vs ofatumumab in relapsed and refractory CLL/SLL

Ian W. Flinn, Peter Hillmen, Marco Montillo et al. · Blood · 2018 · 331 citations · Full text

Rows per page

1–5 of 85